Gene · 5608
Papers2,492
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,492
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RMR-Related MAP2K6 Gene Variation on the Risk of Overweight/Obesity in Children: A 3-Year Panel Study. | J Pers Med | 2021 | 33540643 | PubTator, text mining | PubMed |
| Anwulignan is a novel JAK1 inhibitor that suppresses non-small cell lung cancer growth. | J Cell Mol Med | 2021 | 33523587 | PubTator, text mining | PubMed |
| Acquisition of Letrozole Resistance Through Activation of the p38/MAPK Signaling Cascade. | Anticancer Res | 2021 | 33517263 | PubTator, text mining | PubMed |
| Effects of Vitrification on the Blastocyst Gene Expression Profile in a Porcine Model. | Int J Mol Sci | 2021 | 33513717 | PubTator, text mining | PubMed |
| Going, Toll-like receptors in skin inflammation and inflammatory diseases. | EXCLI J | 2021 | 33510592 | PubTator, text mining | PubMed |
| Diversity and versatility of p38 kinase signalling in health and disease. | Nat Rev Mol Cell Biol | 2021 | 33504982 | PubTator, text mining | PubMed |
| Integrative analysis of transcriptomic data for identification of T-cell activation-related mRNA signatures indicative of preterm birth. | Sci Rep | 2021 | 33504832 | PubTator, text mining | PubMed |
| Natural and Synthetic Lactones Possessing Antitumor Activities. | Int J Mol Sci | 2021 | 33494352 | PubTator, text mining | PubMed |
| BAFF, involved in B cell activation through the NF-κB pathway, is related to disease activity and bone destruction in rheumatoid arthritis. | Acta Pharmacol Sin | 2021 | 33483588 | PubTator, text mining | PubMed |
| Comprehensive Review of Methodology to Detect Reactive Oxygen Species (ROS) in Mammalian Species and Establish Its Relationship with Antioxidants and Cancer. | Antioxidants (Basel) | 2021 | 33477494 | PubTator, text mining | PubMed |
| Proanthocyanidins and Flavan-3-ols in the Prevention and Treatment of Periodontitis-Immunomodulatory Effects, Animal and Clinical Studies. | Nutrients | 2021 | 33467650 | PubTator, text mining | PubMed |
| Novel pharmacotherapy: NNI-362, an allosteric p70S6 kinase stimulator, reverses cognitive and neural regenerative deficits in models of aging and disease. | Stem Cell Res Ther | 2021 | 33436007 | PubTator, text mining | PubMed |
| The role of E3 ubiquitin ligases in the development and progression of glioblastoma. | Cell Death Differ | 2021 | 33432111 | PubTator, text mining | PubMed |
| Epithelial-Mesenchymal Transition and MicroRNAs in Colorectal Cancer Chemoresistance to FOLFOX. | Pharmaceutics | 2021 | 33429840 | PubTator, text mining | PubMed |
| Genetic regulation of liver lipids in a mouse model of insulin resistance and hepatic steatosis. | Mol Syst Biol | 2021 | 33417276 | PubTator, text mining | PubMed |
| Erb‑B2 Receptor Tyrosine Kinase 2 is negatively regulated by the p53‑responsive microRNA‑3184‑5p in cervical cancer cells. | Oncol Rep | 2021 | 33416166 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| β-catenin regulates FOXP2 transcriptional activity via multiple binding sites. | FEBS J | 2021 | 33284517 | PubTator, text mining | PubMed |
| Integration of transcriptomic, proteomic and metabolomic data to reveal the biological mechanisms of AAI injury in renal epithelial cells. | Toxicol In Vitro | 2021 | 33212167 | PubTator, text mining | PubMed |
| The nuclear factor CECR2 promotes somatic cell reprogramming by reorganizing the chromatin structure. | J Biol Chem | 2021 | 33144328 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5608/papers?page=31